Abstract
Aim The aim of this pilot study is to develop and test a quality of care score for patients with permanent atrial fibrillation (AF) in general practice, and identify the patterns of quality of care using this score.
We developed a quality of care score based on the Atrial Fibrillation Better Care pathway recommended by the European Society of Cardiology and the European Heart Rhythm Association guidelines. This is a 14-point score that we have termed the MAGIC score(Management of Atrial Fibrillation in Integrated Care and General Practice).
Methods & Results An observational cross-sectional pilot study was undertaken. Proportionate sampling was used across 11 practices from the Ireland East practice-based research network. The GPs completed a report form on each patient provided by the research team by undertaking a retrospective chart review.
11 practices participated with a total number of 1855 patients with AF. We received data on 153 patients.
The main findings were that:
No patient met all 14 guideline based recommendations Mean MAGIC score was 11.3
Points were most commonly deducted because the creatinine-clearance and HAS-BLED score were not recorded and the patient was not on the correct dose of oral anti-coagulation.
Conclusion This study demonstrates the feasibility of using a quality of care score to measure quality of AF management in general practice. This scoring system; which is based on internationally recognised quality of care markers, highlights key areas that can be targeted with intervention to improve care.
Competing Interest Statement
The lead author Dr. McErlean receives funding from the Health Service Executive as an Academic Clinical Fellow. The project was funded by the Ireland East Hospital Group and the UCD School of Medicine / College of Health & Agricultural Sciences research fund. Professor Cullen is PI on programme of research on integrated models of care supported by Ireland East Hospital Group who funded this study. Dr. Mark Ledwidge has received funding from Novartis, Abbott Diagnostics, the European Commission Framework Programme 7, Genuity Science, Abbott, and the Health Research Board of the Irish Government outside of this submitted work. Dr. Gallagher is General Practice Lead in Cardiovascular Disease on Integrated Care Programme for Chronic Disease with the Health Service Executive and has received funding for educational activities from Novartis, Astra Zeneca & Daiichi Sankyo. The other authors declare no conflict of interest.
Funding Statement
The project was funded by the Ireland East Hospital Group and the UCD School of Medicine / College of Health & Agricultural Sciences research fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project was approved by the research ethics committee at the Irish College of General Practitioners (ICGP_REC_21_0055).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Sarah.mcerlean{at}ucd.ie / sarahmcerlean{at}gmail.com, +353879259231
Data Availability
All data produced in the present study are available upon reasonable request to the authors
